Skip to main content
Blood Cancer Journal logoLink to Blood Cancer Journal
. 2020 Nov 4;10(11):112. doi: 10.1038/s41408-020-00374-3

Correction: Imatinib mesylate inhibits STAT5 phosphorylation in response to IL-7 and promotes T cell lymphopenia in chronic myelogenous leukemia patients

S Thiant 1,2, M M Moutuou 1,2, P Laflamme 1,2, R Sidi Boumedine 1, D M Leboeuf 3,4, L Busque 1,3, J Roy 1,3, M Guimond 1,2,
PMCID: PMC7643148  PMID: 33149116

Correction to: Blood Cancer Journal

10.1038/bcj.2017.29 published online 7 April 2017

Following the publication of this article the authors noted that Grant numbers were omitted in the Acknowledgements section. This work was supported by grants from the Cancer Research Society of Canada (grants no. 16255 to M.G.) and from the Fond de Recherche Santé Québec (grant no 20219 to J.R.) and in part by the Foundation de l’Hôpital Maisonneuve-Rosemont, Montreal, QC, CAN. The authors wish to apologize for any inconvenience caused.


Articles from Blood Cancer Journal are provided here courtesy of Nature Publishing Group

RESOURCES